# Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.

> **NCT02249208** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Tc+blue dye
- **DEVICE:** Tc+SPIO
- **DEVICE:** SPIO alone

## Key facts

- **NCT ID:** NCT02249208
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249208, "Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02249208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*